Atlas Trials

Innovent Biologics Technology Limited (Shanghai R&D Center)

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Innovent Biologics Technology Limited (Shanghai R&D Center)

RecordFirmDate
Tigulixostat (IBI128) vs Febuxostat in Gout (NCT07414394)Innovent Biologics Technology Limited (Shanghai R&D Center)2026-03-17
This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors (NCT07327632)Innovent Biologics Technology Limited (Shanghai R&D Center)2026-01-29
A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD (NCT07275840)Innovent Biologics Technology Limited (Shanghai R&D Center)2025-12-05
A Study of IBI3032 in Chinese Participants With Overweight or Obesity (NCT07170319)Innovent Biologics Technology Limited (Shanghai R&D Center)2025-09-25
A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity (NCT07160400)Innovent Biologics Technology Limited (Shanghai R&D Center)2025-09-04
A Study of IBI3032 in Chinese Healthy Subjects (NCT07134127)Innovent Biologics Technology Limited (Shanghai R&D Center)2025-08-29
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME） (NCT06908876)Innovent Biologics Technology Limited (Shanghai R&D Center)2025-04-24

Track Innovent Biologics Technology Limited (Shanghai R&D Center) automatically

Every clearance here is in the API, with alerts when new ones post.